Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical efficacy of topical Softacort (hydrocortisone 0.335%) in chronic dry eye disease with ocular surface inflammation
2017-003285-27Phase 4Completed
- Sponsor
- Laboratoires Théa
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydrocortisone in dry eye syndrome (DED) (2 arms), sponsored by Laboratoires Théa. Primary endpoints: Patient satisfaction and Conjunctival hyperemia. Started Aug 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on 2017-003285-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003285-27.